dsip 펩타이드 (5mg vials) DSIP Nasal Spray 5mg —
Description
2014;8(2):2206 Zheng Z, Shi H, Jia J, Li D, Lin S
Thus, to highlight possible application of pentadecapeptide BPC 157 in both IBD and multiple sclerosis patients, this study shows BPC 157's potential to counteract the consequences of the cuprizone application, used in an extremely high regimen that highly exceeds those commonly applied (62)
10.1124/jpet.109.161711 127 YapB
Cycle context Phase 2 protocols ran 12-24 weeks
